Abstract
Objective: To review the scientific literature exploring the new forms of treatment used in non-Hodgkin's lymphoma. Methods: Data collection using the Bireme, Medline, Lilacs and PubMed research platforms uses non-Hodgkin's lymphoma, pharmacological treatment and immunotherapy. Results and discussions: The most common treatment is chemotherapy, radiotherapy is used in restricted cases, in more severe cases, it is not applicable to more traditional treatments, but it can also be used in therapy, such as with the monoclonal antibody Rituximab, which promotes Immune Reactions which lead to apoptosis of tumor cells, in effect in the marrow of the patient. Final Considerations: The Importance of Work is to Contain the Content on the New Therapeutic Conduct Involving Immunotherapy for the Treatment of This neoplasm Given the Progressive Increase in the Number of Cases in the Last 25 Years, Mainly in the Age Group of the 60 Important is that the new forms of treatment used for future research are realistic in the search for better prognosis for this disease.